BioNTech
BNTX
BNTX
354 hedge funds and large institutions have $9.07B invested in BioNTech in 2021 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 124 increasing their positions, 101 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.39% less ownership
Funds ownership: 15.39% → 15% (-0.39%)
9% less capital invested
Capital invested by funds: $10B → $9.07B (-$939M)
17% less call options, than puts
Call options by funds: $1.45B | Put options by funds: $1.74B
Holders
354
Holding in Top 10
7
Calls
$1.45B
Puts
$1.74B
Top Buyers
| 1 | +$166M | |
| 2 | +$137M | |
| 3 | +$102M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$95.4M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$83.8M |
Top Sellers
| 1 | -$396M | |
| 2 | -$278M | |
| 3 | -$259M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$109M |
| 5 |
Millennium Management
New York
|
-$79.2M |